Melissa M. Berrien-Elliott

4.5k total citations · 1 hit paper
49 papers, 1.9k citations indexed

About

Melissa M. Berrien-Elliott is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Melissa M. Berrien-Elliott has authored 49 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Immunology, 28 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Melissa M. Berrien-Elliott's work include Immune Cell Function and Interaction (42 papers), CAR-T cell therapy research (26 papers) and T-cell and B-cell Immunology (19 papers). Melissa M. Berrien-Elliott is often cited by papers focused on Immune Cell Function and Interaction (42 papers), CAR-T cell therapy research (26 papers) and T-cell and B-cell Immunology (19 papers). Melissa M. Berrien-Elliott collaborates with scholars based in United States, United Kingdom and Spain. Melissa M. Berrien-Elliott's co-authors include Todd A. Fehniger, Julia A. Wagner, Timothy Schappe, Rizwan Romee, Jeffrey Leong, Brea A. Jewell, Sara Abdel-Latif, Maximillian Rosario, Carly C. Neal and Megan A. Cooper and has published in prestigious journals such as Journal of Clinical Investigation, Blood and The Journal of Immunology.

In The Last Decade

Melissa M. Berrien-Elliott

46 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia

2016 660 citations Rizwan Romee, Maximillian Rosario et al. Science Translational Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Melissa M. Berrien-Elliott United States	19	1.5k	1.0k	339	253	143	49	1.9k
Ranjani Rajapaksa United States	17	1.3k 0.9×	807 0.8×	605 1.8×	333 1.3×	175 1.2×	23	1.9k
Aniruddha Choudhury Sweden	20	1.2k 0.8×	909 0.9×	460 1.4×	192 0.8×	92 0.6×	38	1.7k
Valarie McCullar United States	23	2.2k 1.5×	1.2k 1.1×	477 1.4×	718 2.8×	103 0.7×	32	2.8k
Peggy A. Bulur United States	13	860 0.6×	544 0.5×	302 0.9×	155 0.6×	104 0.7×	27	1.3k
Rinat Rotem‐Yehudar Israel	11	1.3k 0.9×	1.2k 1.2×	469 1.4×	430 1.7×	124 0.9×	20	2.0k
Agnès Moreau‐Aubry France	17	806 0.5×	433 0.4×	448 1.3×	108 0.4×	94 0.7×	30	1.3k
Tim Luetkens United States	23	718 0.5×	658 0.7×	469 1.4×	416 1.6×	84 0.6×	57	1.4k
Bartosz Grzywacz United States	14	960 0.6×	597 0.6×	204 0.6×	266 1.1×	95 0.7×	31	1.2k
Eugen Leo Germany	15	705 0.5×	783 0.8×	748 2.2×	374 1.5×	217 1.5×	42	1.9k
Felix S. Lichtenegger Germany	18	698 0.5×	684 0.7×	428 1.3×	440 1.7×	112 0.8×	35	1.3k

Countries citing papers authored by Melissa M. Berrien-Elliott

Since Specialization

Citations

This map shows the geographic impact of Melissa M. Berrien-Elliott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa M. Berrien-Elliott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa M. Berrien-Elliott more than expected).

Fields of papers citing papers by Melissa M. Berrien-Elliott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa M. Berrien-Elliott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa M. Berrien-Elliott. The network helps show where Melissa M. Berrien-Elliott may publish in the future.

Co-authorship network of co-authors of Melissa M. Berrien-Elliott

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa M. Berrien-Elliott. A scholar is included among the top collaborators of Melissa M. Berrien-Elliott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa M. Berrien-Elliott. Melissa M. Berrien-Elliott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vadakekolathu, Jayakumar, Laura Arthur, Melissa Tran, et al.. (2024). W-NK1 Choreographs Innate and Adaptive Immune Responses to Provide a Robust and Durable Anti-AML Response. Blood. 144(Supplement 1). 916–916. 3 indexed citations

Cubitt, Celia C., Pamela Wong, Jennifer A. Foltz, et al.. (2024). Induced CD8α identifies human NK cells with enhanced proliferative fitness and modulates NK cell activation. Journal of Clinical Investigation. 134(15). 3 indexed citations

O’Neal, Julie, Matthew Cooper, Julie Ritchey, et al.. (2023). Anti-myeloma efficacy of CAR-iNKT is enhanced with a long-acting IL-7, rhIL-7-hyFc. Blood Advances. 7(20). 6009–6022. 20 indexed citations

Rutella, Sergio, Amanda F. Cashen, John Muth, et al.. (2023). S129: ADOPTIVELY INFUSED MEMORY-LIKE (ML) NATURAL KILLER (NK) CELLS ELICIT ADAPTIVE IMMUNE RESPONSES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML). HemaSphere. 7(S3). e4299744–e4299744. 1 indexed citations

Muz, Barbara, Xiaohua Li, Gregory S. Watson, et al.. (2023). Abstract 6418: xWU-NK-101 as salvage therapy post immune checkpoint blockade (ICB). Cancer Research. 83(7_Supplement). 6418–6418.

Rutella, Sergio, John Muth, Jayakumar Vadakekolathu, et al.. (2023). WU-NK-101 (W-NK), a Memory-like (ML) NK Cell, Intrinsically Overcomes Factors Restricting Adoptive Cell Therapy (ACT) in Acute Myeloid Leukemia (AML). Blood. 142(Supplement 1). 466–466. 1 indexed citations

Berrien-Elliott, Melissa M., Miriam T. Jacobs, & Todd A. Fehniger. (2022). Allogeneic natural killer cell therapy. Blood. 141(8). 856–868. 109 indexed citations

Marín, Nancy D., Bradley A. Krasnick, Michelle Becker‐Hapak, et al.. (2021). Memory-like Differentiation Enhances NK Cell Responses to Melanoma. Clinical Cancer Research. 27(17). 4859–4869. 44 indexed citations

Ward, Jeffrey P., Melissa M. Berrien-Elliott, Felicia Gomez, et al.. (2021). Phase 1/dose expansion trial of brentuximab vedotin and lenalidomide in relapsed or refractory diffuse large B-cell lymphoma. Blood. 139(13). 1999–2010. 23 indexed citations

10.

Dege, Carissa, Katherine H. Fegan, Melissa M. Berrien-Elliott, et al.. (2020). Potently Cytotoxic Natural Killer Cells Initially Emerge from Erythro-Myeloid Progenitors during Mammalian Development. Developmental Cell. 53(2). 229–239.e7. 67 indexed citations

11.

Foltz, Jennifer A., Melissa M. Berrien-Elliott, Carly C. Neal, et al.. (2019). Cytokine-Induced Memory-like (ML) NK Cells Persist for > 2 Months Following Adoptive Transfer into Leukemia Patients with a MHC-Compatible Hematopoietic Cell Transplant (HCT). Blood. 134(Supplement_1). 1954–1954. 16 indexed citations

12.

Trissal, Maria, Terrence N. Wong, Juo-Chin Yao, et al.. (2018). MIR142 Loss-of-Function Mutations Derepress ASH1L to Increase HOXA Gene Expression and Promote Leukemogenesis. Cancer Research. 78(13). 3510–3521. 34 indexed citations

13.

Berrien-Elliott, Melissa M., Rizwan Romee, Julia A. Wagner, et al.. (2017). NKG2A Represents an Important Immune Checkpoint for Human Cytokine-Induced Memory-like NK Cells in Patients with AML. Blood. 130. 167–167. 2 indexed citations

14.

Berrien-Elliott, Melissa M., et al.. (2016). Rescue of Tolerant CD8+ T Cells during Cancer Immunotherapy with IL2:Antibody Complexes. Cancer Immunology Research. 4(12). 1016–1026. 13 indexed citations

15.

Krysiak, Kilannin, Felicia Gomez, Brian S. White, et al.. (2016). Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma. Blood. 129(4). 473–483. 110 indexed citations

16.

Cantoni, Claudia, Francesca Cignarella, Laura Ghezzi, et al.. (2016). Mir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Acta Neuropathologica. 133(1). 61–77. 76 indexed citations

17.

Romee, Rizwan, Maximillian Rosario, Melissa M. Berrien-Elliott, et al.. (2016). Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia. Science Translational Medicine. 8(357). 357ra123–357ra123. 660 indexed citations breakdown →

18.

Berrien-Elliott, Melissa M., et al.. (2014). Checkpoint Blockade Immunotherapy Relies on T-bet but Not Eomes to Induce Effector Function in Tumor-Infiltrating CD8+ T Cells. Cancer Immunology Research. 3(2). 116–124. 28 indexed citations

19.

Jackson, Stephanie R., et al.. (2013). CD8⁺T Cell Exhaustion During Persistent Viral Infection is Regulated Independently of the Virus-Specific T Cell Receptor. Immunological Investigations. 42(3). 204–220. 8 indexed citations

20.

Berrien-Elliott, Melissa M., Stephanie R. Jackson, Hideo Yagita∥, et al.. (2012). Durable Adoptive Immunotherapy for Leukemia Produced by Manipulation of Multiple Regulatory Pathways of CD8+ T-Cell Tolerance. Cancer Research. 73(2). 605–616. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact